Newsletter | August 2, 2019

08.02.19 -- Phase I Through Late Phase: Study Trends And Market Outlook

 

ISR Reports is a market research firm that operates exclusively in the life sciences industry. These reports offer a 4-year examination of the industry’s Phase I, Phase II/III, and Late Phase market dynamics, such as study volume and outsourced spend. They can be purchased through the links below. You can also access a free preview file.

Phase I Study Trends And Market Outlook
 

A Study Trends and Market Outlook report aims at providing our readers with a detailed view of the clinical development space. The data for this market research report comes from over 140 Phase I decision-makers who were surveyed to share their insights into where the Phase I market is now and where it’s expected to head over the next four years.

Phase II/III Study Trends And Market Outlook
 

For this report, 139 Phase II/III decision-makers were surveyed to share their insights into where the Phase II/III market is now and where it’s expected to head over the next four years.

Late Phase Study Trends And Market Outlook
 

For this report, 115 Late Phase decision-makers were surveyed to share their insights into where the Late Phase market is now and where it’s expected to head over the next four years.

 


 

CLINICAL MARKET RESEARCH REPORTS

ISR Reports is a full-service market research company and sister company of Clinical Leader. Operating exclusively in the pharmaceutical and pharmaceutical services industry, their syndicated and custom market research capabilities enable their customers to make smarter, more informed business decisions.

 

Topics include: Patient recruitment, enrollment, and retention barriers, Study protocol design, Investigator and site selection, Clinical study feasibility strategies and best practices, Use of CROs and specialty providers, and Recruitment strategies.

 

Check out ISR's Syndicated Clinical Market Research Reports